153025-65-1

Basic information

• Product Name: Benzoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, ethyl ester
• CAS NO: 153025-65-1
• Molecular Formula: C15H24O3Si
• Molecular Weight: 280.439
• Mol File: 153025-65-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, ethyl ester(153025-65-1)
• EPA Substance Registry System: Benzoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, ethyl ester(153025-65-1)

Safety Data

• Hazardous Substances Data: 153025-65-1(Hazardous Substances Data)

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 678187-53-6 (tert-butyldimethylsilyl)diphenylphosphine 

Downstream Products

• 49669-22-9 6,6'-Dibromo-2,2'-bipyridine 
• 1357255-88-9 dimethyl 2-{4-[(tert-butyldimethylsilyl)oxy]phenyl}-2-oxoethylphosphonate 
• 1357255-90-3 4-{2-[(2S,6R)-6-(4-bromophenyl)tetrahydro-2H-pyran-2-yl]ethyl}phenol 
• 1357255-89-0 2-[(2S,6R)-6-(4-bromophenyl)tetrahydro-2H-pyran-2-yl]-1-(4-hydroxyphenyl)ethanone 
• 1220307-39-0 3-(4-tert-butyldimethylsilyloxyphenyl)-3-ethoxycarbonyl-3-hydroxy-2-methylenepropanenitrile 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 161584-87-8 Bis(6-bromo-2-pyridyl)<4-((tert-butyldimethylsilyl)oxy)phenyl>methanol 

Relevant articles and documents

Activation of silylphosphines by diethyl azodicarboxylate: Novel silylation of alcohols

A novel activation mode of silylphosphines and an application of that to silylation of alcohols were described. Silylphosphines were found to be instantly activated by means of DEAD and PPTS to form reactive silyl cation equivalents. By using the activate

2-Pyrrolidinone derivatives as HIV protease inhibitors

Compounds of the form,ψ ψ A-B-G-Jψ ψ wherein A is an amine protecting group and the like, B an amino acid or analog thereof, wherein G is ψψ ψand J a small terminal group are described. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.ψ